10.1186/2228-5326-3-48

Optimization of preparation of chitosan-coated iron oxide nanoparticles for biomedical applications by chemometrics approaches

  1. Department of Pharmacy, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, 48189, IR
  2. Department of Chemistry, Faculy of Basic Sciences, Golestan University, Gorgan, 4913815759, IR
Cover Image

Published in Issue 2013-08-23

How to Cite

Honary, S., Ebrahimi, P., Rad, H. A., & Asgari, M. (2013). Optimization of preparation of chitosan-coated iron oxide nanoparticles for biomedical applications by chemometrics approaches. International Nano Letters, 3(1 (December 2013). https://doi.org/10.1186/2228-5326-3-48

PDF views: 113

HTML views: 31

Abstract

Abstract Functionalized magnetic nanoparticles are used in several biomedical applications, such as drug delivery, magnetic cell separation, and magnetic resonance imaging. Size and surface properties of iron oxide nanoparticles are the two important factors which could dramatically affect the nanoparticle efficiency as well as their stability. In this study, the chemometrics approach was applied to optimize the coating process of iron oxide nanoparticles. To optimize the size of nanoparticles, the effect of two experimental parameters on size was investigated by means of multivariate analysis. The factors considered were chitosan molecular weight and chitosan-to-tripolyphosphate concentration ratio. The experiments were performed according to face-centered cube central composite response surface design. A second-order regression model was obtained which characterized by both descriptive and predictive abilities. The method was optimized with respect to the percent of Z average diameter’s increasing after coating as response. It can be concluded that experimental design provides a suitable means of optimizing and testing the robustness of iron oxide nanoparticle coating method.

Keywords

  • Experimental design,
  • Optimization,
  • Nanoparticles,
  • Iron oxide,
  • Coating

References

  1. Corrot et al. (2006) Recent advances in iron oxide nanocrystal technology for medical imaging (pp. 1471-1504) https://doi.org/10.1016/j.addr.2006.09.013
  2. Pankhurst et al. (2003) Applications of magnetic nanoparticles in biomedicine https://doi.org/10.1088/0022-3727/36/13/201
  3. Dobson (2006) Magnetic nanoparticles for drug delivery (pp. 55-60) https://doi.org/10.1002/ddr.20067
  4. Tartaj et al. (2003) The preparation of magnetic nanoparticles for applications in biomedicine (pp. R182-197) https://doi.org/10.1088/0022-3727/36/13/202
  5. Gupta and Gupta (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications (pp. 3995-4021) https://doi.org/10.1016/j.biomaterials.2004.10.012
  6. McNeil and Leukocyte (2005) Nanotechnology for the biologist (pp. 585-594)
  7. Frullano and Meade (2007) Multimodal MRI contrast agents (pp. 939-949) https://doi.org/10.1007/s00775-007-0265-3
  8. Chouly et al. (1996) Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution (pp. 245-255) https://doi.org/10.3109/02652049609026013
  9. Gref et al. (2000) Muller, 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids Surf (pp. 301-313) https://doi.org/10.1016/S0927-7765(99)00156-3
  10. Moghimi et al. (2001) Long-circulating and target-specific nanoparticles: theory to practice (pp. 283-318)
  11. Berry and Curtis (2003) Functionalisation of magnetic nanoparticles for applications in biomedicine (pp. R198-206) https://doi.org/10.1088/0022-3727/36/13/203
  12. Tartaj et al. (2005) Advances in magnetic nanoparticles for biotechnology applications (pp. 28-34) https://doi.org/10.1016/j.jmmm.2004.11.155
  13. Majeti and Kumar (2000) A review of chitin and chitosan applications (pp. 1-27) https://doi.org/10.1016/S1381-5148(00)00038-9
  14. Bouchemal et al. (2004) Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation (pp. 241-251) https://doi.org/10.1016/j.ijpharm.2004.05.016
  15. Chopra et al. (2007) Motwani, Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design (pp. 73-82) https://doi.org/10.1016/j.ejpb.2006.09.001
  16. Ki Do et al. (2004) Optimization of experimental conditions based on the Taguchi robust design for the formation of nano-sized silver particles by chemical reduction method (pp. 55-61) https://doi.org/10.1016/j.cej.2004.08.003
  17. Gonzalez (1993) Optimization of pharmaceutical formulations based on response-surface experimental design (pp. 149-159) https://doi.org/10.1016/0378-5173(93)90135-3